Editas Medicine, Inc. (NASDAQ:EDIT) Moving Today – Down $0.85 – First News 24
|
Editas Medicine, Inc. (NASDAQ:EDIT) Moving Today – Down $0.85
First News 24 CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular … |
FierceBiotech |
Rubius names ex-GlaxoSmithKline VP as CMO as CAR–T rivals near clinic
FierceBiotech Rubius Therapeutics has lured Chris Carpenter, M.D., Ph.D., away from GlaxoSmithKline to serve as its CMO. Carpenter will work as point person on Rubius’ clinical development activities as it gears up to move the first of its CAR–T-rivaling cell … |
Genetic Engineering & Biotechnology News |
Manipulating Water Content in Stem Cells Influences Differentiation Fate
Genetic Engineering & Biotechnology News Scientists in the U.S. have shown that intentionally altering the amount of water in cells to change their volume impacts directly on cell stiffness, which can influence the direction of stem cell differentiation, a finding that could have implications … |